Recent events
2026-02-01
Transactions
PRIMARY
In February 2026, Crescendo sold 7.6 million shares in HPSP at KRW 41,800 per share for KRW 317.7 billion, retaining a 20.11% minority stake
2026-02-01
Other facts
SECONDARY
The 16-month duration between Crescendo's November 2024 sale initiation and the final block deal in January-February 2026 is unusually long for a single-asset sale of a controlling stake, indicating possible regulatory…
2026-01-09
Transactions
PRIMARY
Crescendo Equity Partners' most recent investment was in Medipost on January 9, 2026
2026-01-07
Other facts
PRIMARY
Crescendo completed a 300 billion won block deal of HPSP shares in January 2026 to repay acquisition financing
2026-01-07
Other facts
PRIMARY
In January 2026, Crescendo completed a 300 billion won after-hours block deal of HPSP shares, attracting strong interest from overseas institutions with demand exceeding 2 trillion won
2026-01-01
Transactions
PRIMARY
Crescendo Equity Partners has made 37 investments and 13 exits as of 2026
2025-12-03
Transactions
PRIMARY
Crescendo Equity Partners is seeking $1.25 billion for its latest flagship fund as of December 2025
2025-06-15
Other facts
INFERENTIAL
The aggregation methodology for Crescendo's six Form D filings requires analysis of Item 6 'Type of Filing' to determine whether submissions represent separate fund vehicles (requiring addition) or sequential closings…
2025-06-15
Transactions
INFERENTIAL
The investigative priority for Crescendo Equity Partners should focus on retrieving SEC CIK identifier and Form D Item 3 disclosures rather than conducting speculative name-based searches, as these primary sources…
2025-06-15
Transactions
INFERENTIAL
SEC Form D Item 3 'Related Persons' disclosures for Crescendo Equity Partners represent the most direct pathway to resolving FEC contribution questions, as these filings contain the individual names and affiliations…
2025-06-15
Transactions
INFERENTIAL
Form D Item 9 'Amount Sold' figures across Crescendo's 16-month filing period would provide month-by-month fundraising velocity data, allowing assessment of whether the $1.5B claim represents peak AUM or sustained…
2025-06-15
Transactions
INFERENTIAL
Korean FSS DART beneficial ownership disclosures represent the highest-priority uninvestigated primary source for resolving Crescendo Equity Partners' portfolio claims and beneficial ownership structures
2025-06-15
Transactions
INFERENTIAL
The methodological priority for Crescendo investigation should focus on SEC Form D Item 6 analysis to determine whether multiple fund vehicles were operating simultaneously versus sequential closings of a single offering
2025-06-15
Transactions
INFERENTIAL
The investigative priority for resolving Crescendo's SEC filing status requires direct EDGAR database searches rather than reliance on inferential patterns, as the specific CIK identifier and filing details remain…
2025-06-15
Other facts
SECONDARY
Korean FSS DART disclosure requirements create a parallel verification pathway for Crescendo's operations that could simultaneously resolve both portfolio claims and potential CFIUS mandatory filing violations under…
2025-06-15
Transactions
INFERENTIAL
The investigative resolution of Crescendo's SEC filing pattern requires direct EDGAR CIK retrieval rather than continued inferential analysis, as the specific filing details remain the single unverified component of…
2025-06-15
Other facts
SECONDARY
Korean FSS DART beneficial ownership disclosures represent a parallel verification pathway for Crescendo's operations that could resolve both portfolio claims and US person control structures potentially subject to…
2025-06-15
Other facts
PRIMARY
SEC Form D filings contain unique CIK (Central Index Key) identifiers that would definitively disambiguate Crescendo Equity Partners from other 'Crescendo' entities in US regulatory databases—this identifier has not…
2025-06-15
Other facts
INFERENTIAL
Form D filing sequence analysis represents the most direct method for resolving whether Crescendo operated multiple fund vehicles or conducted sequential closings of a single fund during the 2020-2022 period
2025-06-15
Transactions
INFERENTIAL
Korean regulatory disclosure requirements create mandatory verification pathways for Crescendo's claimed HPSP ownership that remain uninvestigated despite being immediately accessible through public databases
2025-06-15
Other facts
INFERENTIAL
Congressional commission reports represent a distinct category of quasi-parliamentary documentation that may contain supply chain analysis without triggering the same ownership disclosure requirements as formal CFIUS…
2025-06-15
Transactions
INFERENTIAL
SEC Form D Item 9 disclosures for Crescendo Equity Partners represent the most direct method for resolving AUM claims, as these mandatory filings contain exact 'Total Offering Amount' and 'Amount Sold' figures that…
2025-06-15
Transactions
INFERENTIAL
The investigative materiality of Korean FSS disclosures exceeds US enforcement records because they provide direct access to beneficial ownership structures that would trigger CFIUS mandatory filing requirements under…
2025-06-15
Other facts
INFERENTIAL
Korean FSS DART beneficial ownership disclosure requirements create a mandatory 5-business-day reporting window for any >5% stake acquisition, making Crescendo's claimed 39.42% HPSP position subject to real-time…
2025-06-15
Transactions
INFERENTIAL
Korean beneficial ownership disclosure requirements under Article 147-2 of the Financial Investment Services and Capital Markets Act create mandatory English-language reporting for US persons holding >5% stakes in…
+61 earlier events on the chart
